KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Goodwill (2017 - 2026)

Elanco Animal Health's Goodwill history spans 9 years, with the latest figure at $4.8 billion for Q4 2025.

  • On a quarterly basis, Goodwill rose 8.27% to $4.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.8 billion, a 8.27% increase, with the full-year FY2025 number at $4.8 billion, up 8.27% from a year prior.
  • Goodwill hit $4.8 billion in Q4 2025 for Elanco Animal Health, roughly flat from $4.8 billion in the prior quarter.
  • Over the last five years, Goodwill for ELAN hit a ceiling of $6.2 billion in Q2 2021 and a floor of $4.4 billion in Q4 2024.
  • Historically, Goodwill has averaged $5.4 billion across 5 years, with a median of $5.4 billion in 2022.
  • Biggest five-year swings in Goodwill: soared 104.96% in 2021 and later fell 26.12% in 2024.
  • Tracing ELAN's Goodwill over 5 years: stood at $6.2 billion in 2021, then fell by 2.9% to $6.0 billion in 2022, then dropped by 15.0% to $5.1 billion in 2023, then dropped by 13.35% to $4.4 billion in 2024, then grew by 8.27% to $4.8 billion in 2025.
  • Business Quant data shows Goodwill for ELAN at $4.8 billion in Q4 2025, $4.8 billion in Q3 2025, and $4.8 billion in Q2 2025.